Gamma Biologicals Realigns Management Team.

HOUSTON--(BUSINESS WIRE)--Oct. 8, 1996--Gamma Biologicals, Inc. (Amex: GBL) announced today that Jimmie L. Turner, formerly vice president -- customer services, has been named chief operating officer of the company.

His prior duties will be assumed by Gary L. Parrish as vice president -- national sales & customer services. The president's title will revert to David E. Hatcher, chairman and CEO.

John J. Moulds, MT(ASCP)SBB, who had been president and COO, will remain a director of the company as well as its chief science officer.

Additionally, the board of directors announced the appointments of four new vice presidents: Raul Alvarez, vice president -- international business; Susan (Sue) Batcha, MT(ASCP)SBB, vice president -- manufacturing; Thomas H. Frame, FIBMS, vice president -- research & development; and Marilyn Moulds, MT(ASCP)SBB, vice president -- consultation & education. All were previously department managers.

"Jimmie Turner knows Gamma's employees, customers and products, having been with the company for 20 years," said Hatcher. "We are pleased to promote such a capable member of the management team."

Turner joined Gamma in 1976 as a sales representative and became vice president -- customer services in 1989. He has been actively involved in preparing bids and negotiating contracts with the large group purchasing organizations formed to help the health care professions control costs. About 50 percent of the company's domestic business currently channels through these groups.

"Gamma has always prided itself on its highly qualified staff, and the board is pleased to recognize the outstanding service and contributions made by these four individuals," said David E. Hatcher, chairman and CEO.

Alvarez came to Gamma in 1994 to focus on international sales, especially to Latin and South America. Previously, he had been division general manager of Menarini Diagnostics in Barcelona, Spain and Florence, Italy. His ability to converse in English, Spanish, Italian and Portuguese is an important asset when working with Gamma's international distributors.

Batcha is responsible for getting products from the drawing board into customers' laboratories. Approximately 40 percent of Gamma personnel report through her. She joined the company in 1981 in Coombs manufacturing, later becoming department supervisor, and was named director of manufacturing in 1989.

Frame, an internationally known scientist in heterohybridoma technology, came to Gamma in 1993 from the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service. As the primary scientist on the Gamma ReACT(TM) system, he identified the adherence principle being incorporated into that microcolumn gel technology.

Marilyn Moulds, well known within the blood banking community, joined Gamma in 1975 as supervisor of consultation & education. She was named director, consultation & education in 1989. The consultation laboratory investigates patient samples for Gamma customers, while the education program assists customers in learning about new products and the proper use of reagent products.

Gamma Biologicals manufactures and sells a wide variety of highly refined and specialized testing products known as in-vitro diagnostic reagents. The company markets to blood donation centers (commonly called "blood banks"), transfusion departments of hospitals, medical laboratories and research institutions. Gamma's common stock trades on the American Stock Exchange using the symbol GBL.

CONTACT: Gamma Biologicals Inc.

David E. Hatcher, 713/681-8481.